FDA Panel Backs Use Of Amgen's Aranesp For Kidney Disease Patients - Wall Street Journal PDF Print
Wall Street JournalThe agency's cardiovascular and renal drugs advisory panel is currently meeting to discuss whether the use of Aranesp in patients with kidney disease should

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.